alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2014212EN.01004602.xml

| 7.7.2014 | EN | Official Journal of the European Union | C 212/46 |
| --- | --- | --- | --- |

7.7.2014

EN

Official Journal of the European Union

C 212/46

---

Action brought on 19 May 2014 — ZZ v Commission

(Case F-45/14)

2014/C 212/60

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: D. de Abreu Caldas, M. de Abreu Caldas, J.-N. Louis, lawyers)

Applicant:

Defendant: European Commission

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Annulment of the decision concerning the transfer of the applicant’s pension rights to the European Union pension scheme applying the new GIP on Articles 11 and 12 of Annex VIII to the Staff Regulations

Form of order sought

Form of order sought

| — | Annul the decision of 25 September 2013 calculating the bonus to his pension rights acquired before his entry into service in the Commission; |
| --- | --- |

—

Annul the decision of 25 September 2013 calculating the bonus to his pension rights acquired before his entry into service in the Commission;

| — | Order the Commission to pay the costs. |
| --- | --- |

—

Order the Commission to pay the costs.

---
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1150 Calibrator. ( a ) *Identification.* A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)
( b ) *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
[52 FR 16122, May 1, 1987, as amended at 84 FR 71796, Dec. 30, 2019]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

###### United States Mint

# AGENCY:

United States Mint, Department of the Treasury.

# ACTION:

Notice.

# SUMMARY:

The United States Mint is announcing the prices of the 2010 United States Mint America the Beautiful Quarters Proof Set; 2010 United States Mint America the Beautiful Quarters Silver Proof Set; 2010 United States Mint Uncirculated Coin Set; 2010 United States Mint Proof Set; and 2010 United States Mint Silver Proof Set.

The 2010 United States Mint America the Beautiful Quarters Proof Set will be priced at $14.95.

The 2010 United States Mint America the Beautiful Quarters Silver Proof Set will be priced at $32.95.

The 2010 United States Mint Uncirculated Coin Set will be priced at $31.95.

The 2010 United States Mint Proof Set will be priced at $31.95.

The 2010 United States Mint Silver Proof Set will be priced at $56.95.

                        The release dates for these sets will be available on the United States Mint Web site at                         *www.usmint/​catalog*.                    

# FOR FURTHER INFORMATION CONTACT:

                        B. B. Craig, Associate Director for Sales and                               ( print page 10346)                            Marketing; United States Mint; 801 9th Street, NW., Washington, DC 20220; or call 202-354-7500.                    

Authority:31 U.S.C. 5111, 5112 & 9701.

Dated: February 26, 2010.

Edmund C. Moy,

Director,  United States Mint.

[FR Doc. 2010-4534 Filed 3-4-10; 8:45 am]

BILLING CODE P
Exhibit 32.2

CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant
to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Financial Officer of
The Timberland Company (the "Company"), does hereby certify that to the undersigned's knowledge:



| |  |  | /s/BRIAN P. MCKEONBrian P. McKeon
Chief Financial Officer
| |  |  | ---------------------------------------------------------

Date:
November 10, 2003

The
foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of
Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.

A
signed original of this written statement, required by Section 906, has been provided to The Timberland Company and will be retained by The Timberland Company and furnished to the Securities
and Exchange Commission or its staff upon request.

---

QuickLinks
<PAGE>


                                                                   Exhibit 10.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of W.P. Stewart & Co., Ltd. (the "Company")
on Form 20-F for the period ended December 31, 2002, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350 as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of
his knowledge:

1. The Report fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Date: March 31, 2003


/s/ William P. Stewart, Jr.
---------------------------------
William P. Stewart, Jr.
Chairman and Chief Executive Officer


[A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.]




                                      E-4
§ 520.1962 Promazine. ( a ) *Specifications.* Conforms to N.F. XII for promazine hydrochloride.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in horses* — ( 1 ) *Amount.* Administer 0.45 to 0.9 milligrams per pound of body weight mixed with an amount of feed that will be readily consumed.
( 2 ) *Indications for use.* For quieting excitable, unruly, or intractable horses.
( 3 ) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 28827, May 20, 2014]
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JAN-31-1997
<PERIOD-START>                              FEB-2-1997
<PERIOD-END>                                AUG-2-1997
<CASH>                                          44,513
<SECURITIES>                                         0
<RECEIVABLES>                                   51,262
<ALLOWANCES>                                     8,957
<INVENTORY>                                      4,100
<CURRENT-ASSETS>                               145,658
<PP&E>                                          21,760
<DEPRECIATION>                                  13,925
<TOTAL-ASSETS>                                 219,064
<CURRENT-LIABILITIES>                           96,354
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        200
<COMMON>                                           456
<OTHER-SE>                                      89,081
<TOTAL-LIABILITY-AND-EQUITY>                   219,064
<SALES>                                        386,207
<TOTAL-REVENUES>                               386,207
<CGS>                                          336,346
<TOTAL-COSTS>                                  336,346
<OTHER-EXPENSES>                                83,103
<LOSS-PROVISION>                                   610
<INTEREST-EXPENSE>                               2,357
<INCOME-PRETAX>                               (36,209)
<INCOME-TAX>                                     4,277
<INCOME-CONTINUING>                           (40,905)
<DISCONTINUED>                                 (5,220)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (46,480)
<EPS-PRIMARY>                                   (1.25)
<EPS-DILUTED>                                   (1.25)
        


</TABLE>
1

Brown, Kelly

From: Sasser, Erika

Sent: Tuesday, November 25, 2014 5:14 PM

To: Frey, Nathan J.

Cc: Stewart, Lori; Wesson, Karen; Scavo, Kimber; Curry, Bridgid; Dougherty, Joseph-J; Rush, 

Alan; Henigin, Mary; Hemby, James; Mathias, Scott; Brown, Kelly

Subject: O3 NAAQS NPRM-- EO12866_O3-NAAQS-RIN2060-AP38-NPR-Preamble

Attachments: EO12866_O3-NAAQS-RIN2060-AP38-NPR-Preamble_20141125 (clean).docx; EO12866

_O3-NAAQS-RIN2060-AP38-NPR-Preamble_20141125 (track changes to 10-6 version).docx

Nathan, 

Attached please find final redline and clean versions of the O3 NAAQS NPRM reflecting changes made in response to 

interagency comments. Please let me know if there are any questions about these materials. 

Thanks, 

Erika
§ 582.4521 Monosodium phosphate derivatives of mono- and diglycerides of edible fats or oils, or edible fat-forming fatty acids. ( a ) *Product.* Monosodium phosphate derivatives of mono- and diglycerides of edible fats or oils, or edible fat-forming fatty acids.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
Exhibit 24

                                POWER OF ATTORNEY

The undersigned hereby constitutes and appoints Robert E. Busch and James T.
Foran, and each of them (with full power to act without the other), the true and
lawful attorney-in-fact and agent for and on behalf of the undersigned, and in
the undersigned's name, place and stead, in the undersigned's capacity as a
Director or Officer or both, as the case may be, of Public Service Electric and
Gas Company (the "Registrant") to sign the Registration Statement on Form S-3 to
be filed by the Registrant with the Securities and Exchange Commission for the
registration under the Securities Act of 1933 of $1,000,000,000 aggregate
principal amount of Registrant's Senior Debt Securities and any and all
amendments of such Registration Statement.

IN WITNESS WHEREOF, each of the undersigned has executed this instrument, this
18th day of December, 2001.

/s/ E. JAMES FERLAND                           /s/ ALBERT R. GAMPER, JR.
----------------------                         ----------------------
E. James Ferland                               Albert R. Gamper, Jr.

/s/ CONRAD K. HARPER                           /s/ MARILYN M. PFALTZ
----------------------                         ----------------------
Conrad K. Harper                               Marilyn M. Pfaltz

/s/ PATRICIA A. RADO
----------------------
Patricia A. Rado
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.1435 Single-function, preprogrammed diagnostic computer. ( a ) *Identification.* A single-function, preprogrammed diagnostic computer is a hard-wired computer that calculates a specific physiological or blood-flow parameter based on information obtained from one or more electrodes, transducers, or measuring devices.
( b ) *Classification.* Class II (performance standards).
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.3870 Cannabinoid test system. ( a ) *Identification.* A cannabinoid test system is a device intended to measure any of the cannabinoids, hallucinogenic compounds endogenous to marihuana, in serum, plasma, saliva, and urine. Cannabinoid compounds include *delta*-9-tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene. Measurements obtained by this device are used in the diagnosis and treatment of cannabinoid use or abuse and in monitoring levels of cannabinoids during clinical investigational use.
( b ) *Classification.* Class II (special controls). A cannabinoid test system is not exempt if it is intended for any use other than employment or insurance testing or is intended for Federal drug testing programs. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing, and does not include devices intended for Federal drug testing programs (*e.g.,* programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military).
[52 FR 16122, May 1, 1987, as amended at 84 FR 71799, Dec. 30, 2019]
#### State of Connecticut *v.*Jack L. Roach

*John Q. Hill, Jr.,*assistant attorney general, for the appellee (state).

*Daniel W. Moger, Jr.,*for the appellant (defendant).

Argued October 7

decided October 7, 1969

There being no appeal from the Superior Court in Tolland County now pending, the motion by the state to dismiss the appeal for failure to file an assignment of errors is dismissed.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM PIMCO
ADVISORS HOLDINGS L.P. FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                               2
<SECURITIES>                                         0
<RECEIVABLES>                                   34,202
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                34,202
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 491,852
<CURRENT-LIABILITIES>                           32,406
<BONDS>                                              0
<PREFERRED-MANDATORY>                          459,446<F1>
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   491,852
<SALES>                                              0<F2>
<TOTAL-REVENUES>                                67,434
<CGS>                                                0<F2>
<TOTAL-COSTS>                                        0<F2>
<OTHER-EXPENSES>                                11,728
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 55,706
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             55,706
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    55,706
<EPS-BASIC>                                       1.14
<EPS-DILUTED>                                     1.08
<FN>
<F1>Entity is a partership. Amount shown represents Partners' Capital.
<F2>The partnership is in the service business and has no sales or cost of goods
sold on tangible products.
</FN>


</TABLE>
<PAGE>

                                                                   EXHIBIT 10.32

                           PRINCETON VIDEO IMAGE, INC.
                                15 PRINCESS ROAD
                         LAWRENCEVILLE, NEW JERSEY 08648

                                February 18, 2003

Cablevision Systems Corporation
1111 Stewart Avenue
Bethpage, New York 11714
Attn: General Counsel

      Re:   Proprietary Information Escrow Agreement (the "Escrow Agreement").,
            dated as of June 25, 2002, by and among Princeton Video Image, Inc.,
            Cablevision Systems Corporation and Kramer Levin Naftalis & Frankel
            LLP (the "Escrow Agent")

Dear Sir or Madam:

      This will confirm the agreement between Princeton Video Image, Inc.,
Cablevision Systems Corporation and the Escrow Agent that all references to the
Option Agreement in the Escrow Agreement shall refer to that certain Option
Agreement, dated as of June 25, 2002, by and between Princeton Video Image, Inc.
and Cablevision Systems Corporation, as amended on the date hereof, and as
further amended from time to time by the parties thereto.

      The authorized signatures below will confirm the understanding as set
forth above. Your attention to this matter is greatly appreciated.

                                        Sincerely,

                                        /s/ JAMES GREEN

                                        James Green
                                        President and Chief Operating Officer

ACCEPTED AND AGREED TO:

Cablevision Systems Corporation:        Kramer Levin Naftalis & Frankel LLP:


By: /s/ WILLIAM J. BELL                 By: /s/ JONATHAN S. CAPLAN
    --------------------------------        ------------------------------------
Name:                                   Name:  Jonathan S. Caplan
     -------------------------------          ----------------------------------
Title:                                  Title: Partner
      ------------------------------           ---------------------------------
Date:                                   Date:  February 12, 2003
     -------------------------------          ----------------------------------
SAT Report

PMN Number: P-14-0397

SAT Date: 3/14/2014

Print Date: 7/7/2015

Related cases: Yes

Health related cases: 

Ecotox related cases: 

Concern levels:

Type of Concern: Health Eco Comments

Level of Concern: 1-2 3

 Persistence Bioaccum Toxicity Comments

1 11

Exposure Based Review:

Health: Yes Exposure based testing (health): Reproductive/developmental toxicity

Ecotox: Yes

Routes of exposure: Health: Dermal 

Ecotox: All releases to water

Fate: ;

Keywords:

 Keywords: SENS-S; AQUATOX

Summary of Assessment:

 Fate:

Fate Summary: P-14-0397

FATE: 

log Kow = 4.52 (E) 

S = 40 mg/L at 25 C (M)

VP = 4.6E-5 torr at 25 C (NOMO5)

BP = 348 C (NOMO5) based on 191 C @ 5 mm Hg (M)

H = 7.22E-7 (E)

log Koc = 3.92 (E)

log Fish BCF = 2.65 (E)
log Fish BAF = 1.60 (E) 

POTW removal (%) = 50-90 via sorption

Time for complete ultimate aerobic biodeg = wk

Sorption to soils/sediments = strong

Volatilization half-life from a standard river = 1000 hrs

Volatilization half-life from a standard lake = 580 da

Atmospheric Oxidation Half-life = 13 hr via OH radical

PBT Potential: P1B1

*CEB FATE: Migration to ground water = negl

 Health:

 Health Summary: Expect moderate absorption via all routes (analog). 

Concern for dermal sensitization based on submitted test data.

 Test Data: (-) Salmonella with and without activation; (-) E. coli 

with and without activation; rat oral LD0 = 2000 mg/kg; rat dermal LD0 = 2000 mg/kg; (+) for 

skin sensitization in a mouse local lymph node assay, EC3 = 65%

 Ecotox:

Test 

Organism

Test 

Type

Test End 

Point

Predicted Measured Comments

fish 96-h LC50 1.1

daphnid 48-h LC50 1.7

green algal 96-h EC50 0.493

fish _ chronic 

value

0.048

daphnid _ chronic 

value

0.572

algal _ chronic 

value

0.286

Sewage 

Sludge

3-h EC50 _

Sewage 

Sludge

_ Chronic 

Value

_

Ecotox Values Comments: Predictions are based on SARs for SAR chemical class 

 MW log Kow = 4.5 (EPI); with mp = 9 C(M); S = 9.6 mg/L at 20 C (P); 

pH7; effective concentrations based on 100% active ingredients and mean measured 

concentrations; hardness <180.0 mg/L as CaCO3; and TOC <2.0 mg/L;

Factors Values Comments

Assessment Factor 10

Concentration of Concern 

(ppb) 

Acute 
Concentration of Concern 

(ppb) Chronic

5

SARs

SAR Class

TSCA New Chemcial 

Category 

Ecotox Factors Comments: 

 SAT Chair: 

 Fate assessor: Ecotox assessor: Health assessor:
Exhibit 35.4



|     |  |  |                       |                
|---- |  |  | --------------------- | ---------------
|LOGO |  |  |                       | CMBS Department
|     |  |  | MAC N9401-011        
|     |  |  | 1055 10th Avenue SE  
|     |  |  | Minneapolis, MN 55414

Citigroup Commercial Mortgage Securities,

Inc. 390 GREENWICH ST

NEW YORK, New York 10013-2375



|RE: | Annual Statement of Compliance for Citigroup Commercial Mortgage Trust 2015 Commercial Mortgage Pass-Through Certificates, Series 2015-P1
|--- | -----------------------------------------------------------------------------------------------------------------------------------------

Per the Pooling and Servicing Agreement dated as of August 1, 2015 (the Agreement), the undersigned, a duly authorized officer of Wells Fargo
Bank, N.A., as Custodian (Wells Fargo), hereby certifies as follows as of and for the year ending December 31, 2015 (the Reporting Period):

(a) A review of Wells Fargos activities during the Reporting Period and of its performance under the Agreement has been made under such
officers supervision; and

(b) To the best of such officers knowledge, based on such review, Wells Fargo has fulfilled all of
its obligations under the Agreement in all material respects throughout the Reporting Period.

March 1, 2016



|              
|--------------
|LOGO          
|              
|GAIL VANNEST  
|Vice President



|                       |  |     
|---------------------- |  | ----
|Wells Fargo Bank, N.A. |  | LOGO
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.2550 Pneumotachometer. ( a ) *Identification.* A pneumotachometer is a device intended for medical purposes that is used to determine gas flow by measuring the pressure differential across a known resistance. The device may use a set of capillaries or a metal screen for the resistive element.
( b ) *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 868.9.
[47 FR 31142, July 16, 1982, as amended at 84 FR 71811, Dec. 30, 2019]